| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |